OPTN OptiNose Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OPTN

Price (delayed)

$0.88

Market cap

$99.13M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.32

Enterprise value

$155.68M

Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. ...

Highlights
OPTN's EPS has soared by 63% YoY and by 16% from the previous quarter
OptiNose's net income has soared by 53% YoY and by 13% from the previous quarter
The equity has dropped by 53% year-on-year and by 12% since the previous quarter
The quick ratio has declined by 26% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.optinose.com
Peers: OPK ORGO

Key stats

What are the main financial stats of OPTN
Market
Shares outstanding
112.65M
Market cap
$99.13M
Enterprise value
$155.68M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.19
Earnings
Revenue
$70.99M
EBIT
-$15.96M
EBITDA
-$15.55M
Free cash flow
-$20.86M
Per share
EPS
-$0.32
Free cash flow per share
-$0.19
Book value per share
-$0.77
Revenue per share
$0.63
TBVPS
$0.96
Balance sheet
Total assets
$107.73M
Total liabilities
$194.34M
Debt
$130.23M
Equity
-$86.61M
Working capital
-$71.19M
Liquidity
Debt to equity
-1.5
Current ratio
0.6
Quick ratio
0.53
Net debt/EBITDA
-3.64
Margins
EBITDA margin
-21.9%
Gross margin
87.8%
Net margin
-50%
Operating margin
-32%
Efficiency
Return on assets
-33%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-22.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPTN stock price

How has the OptiNose stock price performed over time
Intraday
-3.3%
1 week
-3.3%
1 month
-37.59%
1 year
-49.13%
YTD
-31.78%
QTD
-39.73%

Financial performance

How have OptiNose's revenue and profit performed over time
Revenue
$70.99M
Gross profit
$62.35M
Operating income
-$22.75M
Net income
-$35.48M
Gross margin
87.8%
Net margin
-50%
The operating income has surged by 59% year-on-year and by 20% since the previous quarter
The operating margin has surged by 56% year-on-year and by 19% since the previous quarter
OptiNose's net income has soared by 53% YoY and by 13% from the previous quarter
OPTN's net margin is up by 49% YoY and by 12% QoQ

Growth

What is OptiNose's growth rate over time

Valuation

What is OptiNose stock price valuation
P/E
N/A
P/B
N/A
P/S
1.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.19
OPTN's EPS has soared by 63% YoY and by 16% from the previous quarter
The equity has dropped by 53% year-on-year and by 12% since the previous quarter
OPTN's price to sales (P/S) is 72% less than its 5-year quarterly average of 4.9 and 37% less than its last 4 quarters average of 2.2
OptiNose's revenue has decreased by 7% YoY

Efficiency

How efficient is OptiNose business performance
OPTN's ROS has soared by 70% YoY and by 26% from the previous quarter
The ROA has grown by 44% YoY and by 5% from the previous quarter

Dividends

What is OPTN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPTN.

Financial health

How did OptiNose financials performed over time
OptiNose's total assets is 45% less than its total liabilities
The quick ratio has declined by 26% year-on-year
OptiNose's total assets has decreased by 25% YoY but it has increased by 6% from the previous quarter
The equity has dropped by 53% year-on-year and by 12% since the previous quarter
OptiNose's debt to equity has increased by 34% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.